Company: TVRD
Filing Date: 2025-10-07
Form Type: S-1/A
Source: 0001104659-25-097519
Chunk: 365

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-10-07
Form: S-1/A
Chunk 365
---
 but before the issuance of the Company’s condensed consolidated financial statements, it is considered a non-recognized subsequent event. Accordingly, the effects of OBBBA are not reflected in the Company’s income tax provision or deferred tax balances as of June 30, 2025. The Company is currently evaluating the impact and will reflect the effects, as appropriate, in future reporting periods.

<div align='center'>F-51</div>

PART II INFORMATION NOT REQUIRED IN PROSPECTUS ITEM 13. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION. The following table sets forth all expenses to be paid by the Registrant, other than underwriting discounts and commissions, in connection with this offering. All amounts shown are estimates.

| SEC registration fee              |     | $ |   9,928 |
| Printing and engraving            |     |   |       * |
| Legal fees and expenses           |     | $ | 150,000 |
| Accounting fees and expenses      |     | $ |  75,000 |
| Transfer agent and registrar fees |     |   |       * |
| Miscellaneous                     |     |   |       * |
| Total                             |     | $ |       * |

| * | These fees are calculated based on the shares of common stock offered and the number of issuances and accordingly cannot be defined at this time. |

ITEM 14. INDEMNIFICATION OF DIRECTORS AND OFFICERS. Our amended and restated certificate of incorporation (the “Charter”) limits the liability of directors to the maximum extent permitted by Delaware law. Delaware law provides that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors, except for liability for any:

| ● | breach of their duty of loyalty to the corporation or our stockholders; |

| ● | act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; |

| ● | unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the Delaware General Corporation Law; or |

| ● | transaction from which the directors derived an improper personal benefit. |

Our Charter does not eliminate a director’s duty of care and, in appropriate circumstances, equitable remedies, such as injunctive or other forms of non-monetary relief, remain available under Delaware law. These limitations also do not affect a director’s responsibilities under any other laws, such as the federal securities laws or other state or federal laws. Our By